产品详情
产品名称BCL-XL(Ab-62) Antibody
来源种属Rabbit
克隆性Polyclonal
纯化Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
应用WB
种属反应性Hu Ms Rt
特异性The antibody detects endogenous level of total BCL-XL protein.
免疫原类型Peptide-KLH
免疫原描述Peptide sequence around aa.60~64 (A-D-S-P-A) derived from human BCL-XL .
基因/蛋白名称BCL-XL
别名Apoptosis regulator Bcl-X
数据库入口号Swiss-Prot: Q07817
NCBI Protein: NP_612815.1
浓度1.0mg/ml
配方Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
保存Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
应用详情
Predicted MW: 30kd
Western blotting: 1:500~1:1000
背景
Potent inhibitor of cell death. Isoform Bcl-X(L) anti-apoptotic activity is inhibited by association with SIVA isoform 1. Inhibits activation of caspases By similarity. Appears to regulate cell death by blocking the voltage-dependent anion channnel (VDAC) by binding to it and preventing the release of the caspase activator, cytochrome c, from the mitochondrial membrane. The Bcl-X(S) isoform promotes apoptosis.
Basu A, et.al.( 2003) Mar 13; 538(1-3): 41-7
Cheng E.H.-Y. et.al. (1996) Nature 379:554-556.
Sattler M. et.al. (1997), Science 275:983-986.
Muchmore S.W.et.al (1996).Nature 381:335-341
Yu J., Zhang L. Mol. (2001)Cell 7:673-682
如果您使用该产品21061发表了文章,请通知我们,让我们可以引用您的文献。
et al,The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell linesInTransl OncolOn 2023 JanbyJeongjae Lee, Bhumsuk Keam et al..PMID:36436443,
, (2023),
PMID: 36436443
et al,PIWI-Interacting RNA-004800 Is Regulated by S1P Receptor Signaling Pathway to Keep Myeloma Cell Survival.In Front Oncol on 2020 Apr 15 by Ma H, Wang H, et al..PMID: 32351883,
, (2020),
PMID: 32351883
et al,Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. In Int J Mol Med on 2019 Jan by DIng Y, Jiang Z, et al..PMID:30431108,
, (2019),
PMID: 30431108
et al,Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. In Int J Mol Med on 2019 Jan by Yu DIng, Zhaochang Jiang, et al..PMID: 30431108 ,
, (2019),
PMID: 30431108
et al,Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. In Int J Mol Med on 2019 Jan by DIng Y, Jiang Z, et al..PMID:30431108,
, (2019),
PMID: 30431108
et al,Autophagy regulates the degeneration of the auditory cortex through the AMPK-mTOR-ULK1 signaling pathway.In Int J Mol Med. On 2018 Apr by Yuan J, Zhao X et al..PMID: 29344647,
, (2018),
PMID: 29344647
et al,Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811.In Am J Transl Res. On 2016 Sep 15 by SH Li, WC Dong et al..PMID:27725861,
, (2016),
PMID: 27725861
查看更多
et al,miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma.In Clin Cancer Res on 2015 May 15 by Yijun Yang , Fei Li et al..PMID:25724519 ,
, (2015),
PMID: 25724519
et al,Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro. In Int J Mol Med on 2013 Apr by Hong-Gang Wang, Xiao-Dan Huang, et al..PMID:
23440283,
, (2013),
PMID: 23440283